Ordinary Rebalance | Solactive China Healthcare Disruption Index | Effective Date 1st September 2023
Solactive China Healthcare Disruption Index:
In the ordinary rebalance, effective open 01.09.2023 the following index composition was implemented:
| 3D MEDICINES INC | 0.5574 % |
| 3SBIO INC | 1.3082 % |
| AKESO INC | 2.3692 % |
| ALIBABA HEALTH INFORMATION TECHNOLOGY LTD | 5.1235 % |
| ANGELALIGN TECHNOLOGY INC | 0.7248 % |
| CANSINO BIOLOGICS INC | 0.7698 % |
| CHINA MEDICAL SYSTEM HOLDINGS LTD | 2.2696 % |
| CSPC PHARMACEUTICAL GROUP LTD | 5.7425 % |
| GENSCRIPT BIOTECH CORP | 3.1841 % |
| GIANT BIOGENE HOLDING CO LTD | 3.0591 % |
| GRAND PHARMACEUTICAL GROUP LTD | 1.1784 % |
| GUSHENGTANG HOLDINGS LTD | 0.8181 % |
| HANSOH PHARMACEUTICAL GROUP CO | 4.9486 % |
| INNOCARE PHARMA LTD | 1.0284 % |
| INNOVENT BIOLOGICS INC | 4.422 % |
| JD HEALTH INTERNATIONAL INC | 7.2394 % |
| JOINN LABORATORIES CHINA C-H | 1.4516 % |
| KEYMED BIOSCIENCES INC | 1.2203 % |
| LIFETECH SCIENTIFIC CORP | 0.9238 % |
| LIVZON PHARMACEUTICAL GROUP INC | 2.5553 % |
| LUYE PHARMA GROUP LTD | 0.8858 % |
| MICROPORT SCIENTIFIC CORP | 2.0121 % |
| PING AN HEALTHCARE AND TECHNOL | 1.7894 % |
| REMEGEN CO LTD-H | 2.3994 % |
| SHANDONG WEIGAO GROUP MEDICAL POLYMER CO LTD | 2.8843 % |
| SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD | 6.0445 % |
| SHANGHAI JUNSHI BIOSCIENCES CO LTD | 2.9773 % |
| SHANGHAI MICROPORT MEDBOT GR | 1.4611 % |
| SIMCERE PHARMACEUTICAL GROUP | 1.331 % |
| SINO BIOPHARMACEUTICAL LTD ORD | 4.5813 % |
| SKB BIO-B ORD H | 1.3711 % |
| WUXI APPTEC CO LTD | 8.293 % |
| WUXI BIOLOGICS CAYMAN INC | 8.6642 % |
| YSB ORD | 2.7181 % |
| ZAI LAB LTD | 1.6932 % |